Why should tolcapone be given at a lower dose to patients with liver cirrhosis?

Clinical Pharmacology and Therapeutics

Volumn 61, Issue 2, 1997, Pages 183-

  Jorga, K ^a   Fotteler, B ^a   Van Brummelen, P ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0013674924     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)